10X Genomics Inc (NASDAQ:TXG)
26.29 USD
-0.630 2.340%Previous Close (in USD) | 26.92 |
---|---|
Change | -0.630 2.340% |
52 W H/L (in USD) | 63.570/32.020 |
EBITDA (in USD) | -156.734M |
PE Ratio | -- |
Volume | 1904822 |
Diluted Eps TTM | -1.92 |
Total Assets (in USD) | 1028.98M |
---|---|
Total Liabilities (in USD) | 223.237M |
Revenue TTM (in USD) | 590.98M |
Cash (in USD) | 219.746M |
Market Cap (in USD) | 6,798.199 M |
Revenue Per Share TTM | 5.085 |
Gross Profit TTM (in USD) | 396.023M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
10X Genomics Inc
6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260
925 401 7300
Employees: 1243
Key Executives
Sr. No. | Name | Title | Year Born |
---|---|---|---|
1. | Dr. Serge Saxonov Ph.D. | Co-Founder, CEO & Director | 1977 |
2. | Dr. Benjamin J. Hindson Ph.D. | Co-Founder, Pres, Chief Scientific Officer & Director | 1975 |
3. | Mr. Justin J. McAnear | Chief Financial Officer | 1976 |
4. | Mr. Eric S. Whitaker Esq. | Chief Legal Officer | 1967 |
5. | Mr. Michael Schnall-Levin | Founding Scientist & CTO | NA |
6. | Ms. Cassie Corneau | Mang. of Investor Relations and Strategic Fin. | NA |
7. | Mr. Jonathan Schimmel | VP of Global Support & Sales Operations | NA |
8. | Ms. Rebecca Port | Chief People Officer | NA |
9. | Ms. Ruth De Backer | Chief Bus. Officer | 1977 |
10. | Mr. Jim Wilbur Ph.D. | Chief Commercial Officer | NA |
Peers
Sector: Healthcare
Industry: Health Information Services
Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
GEHC
GE HealthCare Technologies Inc. |
-0.480 0.613% | 79.19 | 22.390 | 17.331 | 1.782 | 4.792 | 2.179 | 11.791 |
VEEV
Veeva Systems Inc Class A |
+2.530 1.272% | 200.76 | 54.610 | 33.223 | 12.830 | 6.727 | 11.138 | 58.844 |
MTHRF
M3 Inc |
0.000 0.000% | 11.67 | 29.720 | 25.000 | 0.046 | 4.379 | 0.041 | 0.118 |
MTHRY
M3 Inc |
+0.091 1.757% | 5.1925 | 31.840 | 26.247 | 0.047 | 4.597 | 0.041 | 0.118 |
Income Statement
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Income Before Tax | -161.971M | -53.715M | -534.476M | -31.033M | -112.398M |
Minority Interest | - | - | - | - | 0M |
Net Income | -166M | -58.223M | -542.731M | -31.251M | -112.485M |
Selling General Administrative | 298.3M | 257.56M | 202.326M | 130.834M | 87.936M |
Gross Profit | 396.023M | 416.399M | 240.377M | 184.86M | 117.652M |
Reconciled Depreciation | 33.006M | 28.254M | 19.021M | 7.066M | 3.905M |
Ebit | -167.944M | -52.913M | -85.324M | -29.071M | -17.046M |
Ebitda | -161.495M | -53.509M | -82.455M | -26.452M | -13.141M |
Depreciation And Amortization | 6.449M | -0.596M | 2.869M | 2.619M | 3.905M |
Operating Income | -167.944M | -52.913M | -85.324M | -29.071M | -110.764M |
Other Operating Expenses | 684.353M | 543.403M | 384.169M | 274.964M | 164.134M |
Interest Expense | 0.476M | 0.866M | 1.682M | 3.079M | 2.409M |
Tax Provision | 4.029M | 4.508M | 8.255M | 0.218M | 0.087M |
Interest Income | 6.647M | 0.206M | 1.532M | 2.805M | 1.024M |
Net Interest Income | 6.171M | -0.66M | -0.15M | -0.274M | -1.385M |
Income Tax Expense | 4.029M | 4.508M | 8.255M | 0.218M | 0.087M |
Total Revenue | 516.409M | 490.49M | 298.845M | 245.893M | 146.313M |
Total Operating Expenses | 563.967M | 469.312M | 325.701M | 213.931M | 135.473M |
Cost Of Revenue | 120.386M | 74.091M | 58.468M | 61.033M | 28.661M |
Total Other Income Expense Net | 5.973M | -0.802M | -449.152M | -1.962M | -93.192M |
Net Income From Continuing Ops | -166M | -58.223M | -542.731M | -31.251M | -112.485M |
Net Income Applicable To Common Shares | -166M | -58.223M | -542.731M | -31.251M | -112.485M |
Balance Sheet
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Total Assets | 1028.98M | 1018.826M | 929.341M | 605.923M | 124.31M |
Intangible Assets | 22.858M | 25.397M | 22.354M | 0.4M | 0.4M |
Other Current Assets | 16.578M | 14.924M | 29.596M | 8.033M | 3.02M |
Total Liab | 223.237M | 201.258M | 190.269M | 185.84M | 344.297M |
Total Stockholder Equity | 805.743M | 817.568M | 739.072M | 420.083M | -219.987M |
Other Current Liab | 92.454M | 82.535M | 103.009M | 36.842M | 16.607M |
Common Stock | 0.002M | 0.002M | 0.002M | 0.002M | 0.001M |
Capital Stock | 0.002M | 0.002M | 0.002M | 0.002M | 0.001M |
Retained Earnings | -1029.321M | -863.321M | -805.098M | -262.367M | -231.116M |
Good Will | 4.511M | 4.511M | - | - | 0M |
Other Assets | 7.366M | 10.917M | 82.135M | 53.896M | 6.947M |
Cash | 219.746M | 587.447M | 663.603M | 424.166M | 65.08M |
Cash And Equivalents | - | - | - | - | - |
Total Current Liabilities | 130.957M | 110.357M | 118.126M | 63.049M | 32.362M |
Current Deferred Revenue | 7.867M | 5.34M | 4.472M | 3.297M | 2.776M |
Net Debt | -124.57M | -505.469M | -600.625M | -394.447M | -35.404M |
Short Term Debt | 9.037M | 5.131M | 5.936M | 9.882M | 4.187M |
Short Long Term Debt | - | - | - | 9.882M | 4.187M |
Short Long Term Debt Total | 95.176M | 81.978M | 62.978M | 29.719M | 29.676M |
Other Stockholder Equity | 1839.397M | 1680.865M | 1544.218M | 76.571M | 11.165M |
Property Plant Equipment | 289.328M | 230.41M | 72.84M | 48.821M | 11.127M |
Total Current Assets | 635.035M | 747.591M | 774.366M | 480.84M | 106.236M |
Long Term Investments | - | - | - | - | 0M |
Short Term Investments | 210.238M | - | - | - | 0M |
Net Receivables | 104.211M | 85.254M | 51.208M | 33.371M | 29.566M |
Long Term Debt | - | - | - | 19.837M | 25.489M |
Inventory | 81.629M | 59.966M | 29.959M | 15.27M | 8.57M |
Accounts Payable | 21.599M | 17.351M | 4.709M | 13.028M | 8.792M |
Accumulated Other Comprehensive Income | -4.335M | 0.022M | -0.05M | -0.046M | -0.037M |
Non Currrent Assets Other | 7.366M | 10.917M | 12.798M | 76.262M | 6.947M |
Non Current Assets Total | 393.945M | 271.235M | 154.975M | 125.083M | 18.074M |
Capital Lease Obligations | 95.176M | 81.978M | 62.978M | - | 0M |
Long Term Debt Total | - | - | - | 19.837M | 25.489M |
Cash Flow
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Investments | -350.887M | -106.729M | -38.394M | -42.767M | -6.709M |
Total Cashflows From Investing Activities | -350.887M | -106.729M | -38.394M | -42.767M | -6.709M |
Total Cash From Financing Activities | 15.817M | 35.297M | 468.906M | 414.59M | 105.367M |
Net Income | -166M | -58.223M | -542.731M | -31.251M | -112.485M |
Change In Cash | -368.72M | -92.571M | 212.151M | 406.405M | 22.231M |
Begin Period Cash Flow | 596.073M | 688.644M | 476.493M | 70.088M | 47.857M |
End Period Cash Flow | 227.353M | 596.073M | 688.644M | 476.493M | 70.088M |
Total Cash From Operating Activities | -33.606M | -21.373M | -217.898M | 34.627M | -76.409M |
Depreciation | 33.006M | 28.254M | 19.021M | 7.066M | 3.905M |
Other Cashflows From Investing Activities | -4M | -5.451M | -1.728M | - | 0M |
Dividends Paid | - | - | - | - | 0M |
Change To Inventory | -21.192M | -30.132M | -14.601M | -6.699M | -3.732M |
Sale Purchase Of Stock | 21.226M | 40.325M | 506.01M | 0M | 0M |
Other Cashflows From Financing Activities | -5.409M | 35.297M | 17.895M | 14.766M | 104.342M |
Capital Expenditures | 131.661M | 101.278M | 38.394M | 42.767M | 6.709M |
Change In Working Capital | -39.417M | -87.445M | -50.381M | 44.764M | 28.015M |
Other Non Cash Items | 1.957M | 0.079M | 306.017M | 0.101M | 1.247M |
Free Cash Flow | -165.267M | -122.651M | -256.292M | -8.14M | -83.118M |
Funds
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | Scottish Mortgage Ord | 6 months ago | 1786733 |
2. | Brown Capital Mgmt Small Co Inv | 7 months ago | 1653265 |
3. | Fidelity Advisor® Health Care I | 6 months ago | 1581800 |
4. | Vanguard Institutional Extnd Mkt Idx Tr | 5 months ago | 1502056 |
5. | Baillie Gifford US Equity Growth | 6 months ago | 1351761 |
6. | Vanguard US Growth Investor | 7 months ago | 1351761 |
7. | Vanguard Small Cap Growth Index Inv | 5 months ago | 1347994 |
8. | Fidelity Growth Compy Commingled Pl O | 6 months ago | 1343788 |
9. | CS (Lux) Digital Health Equity SB USD | 5 months ago | 1260000 |
10. | T. Rowe Price Health Sciences | 7 months ago | 1224020 |
11. | Nikko AM ARK Disruptive Innovation A USD | 6 months ago | 1064257 |
12. | Baillie Gifford Positive Change | 6 months ago | 1046026 |
13. | Baillie Gifford Positive Change B Acc | 6 months ago | 1033193 |
14. | Vanguard Total Stock Mkt Idx Inv | 5 months ago | 2928761 |
15. | ARK Innovation ETF | 5 months ago | 2652742 |
16. | Vanguard Small Cap Index | 5 months ago | 2407159 |
17. | Fidelity Select Health Care | 6 months ago | 2346051 |
18. | Select Medical Tech and Devcs | 6 months ago | 2252915 |
19. | Fidelity® Growth Company | 6 months ago | 2140034 |
20. | ARK Disruptive Innovation Full Composite | 7 months ago | 2010222 |
Institutions
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | FMR Inc | 7 months ago | 12666998 |
2. | Vanguard Group Inc | 7 months ago | 8903517 |
3. | Baillie Gifford & Co Limited. | 7 months ago | 8340898 |
4. | BlackRock Inc | 7 months ago | 5486294 |
5. | Morgan Stanley - Brokerage Accounts | 7 months ago | 4350050 |
6. | Sands Capital Management, LLC | 7 months ago | 3985470 |
7. | Brown Capital Management, LLC | 7 months ago | 3081105 |
8. | ARK Investment Management LLC | 7 months ago | 2993460 |
9. | T. Rowe Price Associates, Inc. | 7 months ago | 2687451 |
10. | Amvescap Plc. | 7 months ago | 2226466 |
11. | Nikko Asset Management Americas Inc | 7 months ago | 1718471 |
12. | Sumitomo Mitsui Trust Holdings Inc | 7 months ago | 1718471 |
13. | Generation Investment Management LLP | 7 months ago | 1538828 |
14. | RTW INVESTMENTS, LLC | 7 months ago | 1519956 |
15. | Geode Capital Management, LLC | 7 months ago | 1519044 |
16. | State Street Corporation | 7 months ago | 1460637 |
17. | Point72 Asset Management, L.P. | 7 months ago | 1347419 |
18. | Credit Suisse First Boston (CSFB) | 7 months ago | 1337436 |
19. | JPMorgan Chase & Co | 7 months ago | 1232162 |
20. | SRS Investment Management, LLC | 7 months ago | 1049210 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).